HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mitsuho Onimaru Selected Research

Retinaldehyde (Retinal)

11/2008Inhibition of nuclear translocation of apoptosis-inducing factor is an essential mechanism of the neuroprotective activity of pigment epithelium-derived factor in a rat model of retinal degeneration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mitsuho Onimaru Research Topics

Disease

11Neoplasms (Cancer)
01/2016 - 05/2004
10Ischemia
01/2018 - 11/2002
4Hypoxia (Hypoxemia)
10/2012 - 11/2002
2Inflammation (Inflammations)
03/2016 - 01/2015
2Ovarian Neoplasms (Ovarian Cancer)
01/2016 - 03/2011
2Colonic Neoplasms (Colon Cancer)
01/2016 - 03/2011
2Hyperplasia
02/2015 - 08/2005
2Atherosclerosis
01/2015 - 09/2005
2Lymphatic Metastasis
05/2014 - 10/2010
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2014 - 10/2009
2Diabetic Foot
06/2008 - 01/2006
2Diabetic Angiopathies (Diabetic Angiopathy)
06/2008 - 01/2006
2Chronic Limb-Threatening Ischemia
04/2006 - 11/2002
1Vasculitis (Vasculitides)
05/2022
1Aneuploidy (Aneuploid)
11/2016
1Peritonitis
01/2016
1Body Weight (Weight, Body)
01/2016
1Neoplasm Metastasis (Metastasis)
05/2014
1Hemorrhage
08/2013
1Peripheral Arterial Disease
03/2013
1Squamous Cell Carcinoma of Head and Neck
10/2012
1Malignant Mesothelioma
04/2012
1Urinary Bladder Neck Obstruction (Bladder Neck Obstruction)
04/2012
1Infections
04/2012
1Ascites
03/2011
1Glioblastoma (Glioblastoma Multiforme)
10/2010
1Gliosarcoma
10/2010
1Brain Neoplasms (Brain Tumor)
10/2010
1Retinal Degeneration
11/2008
1Blindness (Hysterical Blindness)
11/2008
1Retinitis Pigmentosa (Pigmentary Retinopathy)
11/2008
1Starvation
11/2008
1Diabetes Complications
06/2008
1Macular Degeneration (Age-Related Maculopathy)
11/2006
1Edema (Dropsy)
04/2006
1Metabolic Syndrome (Dysmetabolic Syndrome X)
04/2006
1Atherosclerotic Plaque (Atheroma)
09/2005
1Carcinogenesis
08/2005

Drug/Important Bio-Agent (IBA)

8Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2013 - 05/2004
6Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
03/2013 - 11/2002
4Vascular Endothelial Growth Factor CIBA
10/2010 - 11/2006
4Therapeutic UsesIBA
09/2008 - 11/2002
3Proteins (Proteins, Gene)FDA Link
01/2018 - 11/2002
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
10/2012 - 11/2002
3Messenger RNA (mRNA)IBA
04/2010 - 11/2006
3Becaplermin (PDGF-BB)FDA Link
11/2009 - 01/2006
2Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
01/2018 - 01/2011
2NucleotidesIBA
03/2016 - 01/2015
2Urokinase Plasminogen Activator ReceptorsIBA
04/2012 - 10/2010
2Protein Kinase CIBA
04/2012 - 01/2006
2A-factor (Streptomyces)IBA
02/2011 - 10/2010
2Biomarkers (Surrogate Marker)IBA
10/2010 - 04/2006
2Vascular Endothelial Growth Factor DIBA
10/2009 - 11/2006
2pigment epithelium-derived factorIBA
11/2008 - 09/2005
2Streptozocin (Streptozotocin)FDA Link
06/2008 - 01/2006
2Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
05/2004 - 11/2002
1Antigen-Antibody Complex (Immune Complex)IBA
05/2022
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
05/2022
1benzimidazoleIBA
11/2016
1Fluorouracil (Carac)FDA LinkGeneric
01/2016
1Fibronectins (Fibronectin)IBA
01/2016
1Collagen Type IV (Type IV Collagen)IBA
01/2016
1EnzymesIBA
01/2016
1LipidsIBA
01/2015
1LigandsIBA
01/2015
1Apolipoproteins E (ApoE)IBA
01/2015
1ApolipoproteinsIBA
01/2015
1Biological ProductsIBA
05/2014
1oxidized low density lipoproteinIBA
08/2013
1Liposomes (Liposome)IBA
10/2012
1OligodeoxyribonucleotidesIBA
10/2012
1pyrrolidine dithiocarbamic acidIBA
04/2012
1prolinedithiocarbamate (PDTC)IBA
04/2012
1Carbachol (Carbastat)FDA Link
04/2012
1Viral RNAIBA
04/2012
1SilverIBA
04/2012
1Tretinoin (Retinoic Acid)FDA LinkGeneric
04/2012
1rho-Associated KinasesIBA
04/2012
1Phosphotransferases (Kinase)IBA
03/2011
1CytokinesIBA
01/2011
1Glycoproteins (Glycoprotein)IBA
10/2010
1MucinsIBA
10/2010
1Peptide Hydrolases (Proteases)FDA Link
10/2010
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
10/2010
1InterferonsIBA
10/2010
1Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA
10/2009
1Retinaldehyde (Retinal)IBA
11/2008
1CaspasesIBA
11/2008
1Apoptosis Inducing FactorIBA
11/2008
1NG-Nitroarginine Methyl Ester (L-NAME)IBA
06/2008
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
06/2008
1CCR2 ReceptorsIBA
11/2006
1EdaravoneIBA
04/2006
1Free Radical ScavengersIBA
04/2006
1Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA
01/2006

Therapy/Procedure

5Therapeutics
01/2016 - 08/2005
2Bone Marrow Transplantation (Transplantation, Bone Marrow)
02/2015 - 01/2015
2Immunotherapy
03/2011 - 09/2006
1Ligation
02/2015
1Oral Administration
01/2015